Product Information
Name:Mocetinostat
Controlled Product
Synonyms:
- N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
Brand:TRC
Description:Applications Mocetinostat is a multi-targeted histone deacetylase inhibitor used in cancer therapy. Mocetinostat is undergoing clinical trials for the treatment of various cancers including follicular lymphoma, Hodgkin’s lymphoma and acute myelogenous leukemia.References Ai, T., et al.: Curr. Med. Chem., 19, 475 (2012); Cacasin, M.A., et al.: Circulation Rsch., 110, 739 (2012); Younes, A., et al.: Lancet Oncol., 12, 1222 (2011);
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:396.44
Formula:C23H20N6O
Color/Form:Neat
InChI:InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)
InChI key:InChIKey=HRNLUBSXIHFDHP-UHFFFAOYSA-N
SMILES:Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1
Technical inquiry about: Mocetinostat
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.